Yi Zhou

发表

Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

Tara L. Kieffer, H. Chu, A. Kwong, 2009 .

In Vitro Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of Telaprevir

Tara L. Kieffer, B. G. Rao, O. Nicolas, 2013, Antimicrobial Agents and Chemotherapy.

Observed in Clinical Studies of Telaprevir Hepatitis C Virus NS3 Protease Variants Phenotypic Characterization of In Vitro

Tara L. Kieffer, B. G. Rao, O. Nicolas, 2013 .

Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples

Tara L. Kieffer, A. Kwong, J. Lippke, 2013, Virology Journal.

Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo

R. Doms, Michael Engle, T. Pierson, 2005, Journal of Virology.

Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles

J. Meng, Yi Zhou, Ruihua Shi, 2020, Intervirology.

Hepatitis E virus truncated capsid protein as a potential carrier of exogenous antigens for the development of chimeric virus-like particle vaccines

J. Meng, Yi Zhou, N. Behloul, 2019 .

Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731

R. Colonno, Yi Zhou, R. Yan, 2020, Antimicrobial Agents and Chemotherapy.

The Identification of Novel Small Molecule Inhibitors of West Nile Virus Infection 1 2

S. Diamond, A. Noueiry, B. Geiss, 2007 .

Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors.

E. ter Haar, J. Coll, R. Rijnbrand, 2016, Journal of medicinal chemistry.

Preclinical characterization of ABI-H2158, an HBV core inhibitor with dual mechanisms of action.

Yi Zhou, R. Yan, Dawei Cai, 2022, Antiviral research.

Phenotypic and Structural Analyses of Hepatitis C Virus NS3 Protease Arg155 Variants

A. Kwong, B. G. Rao, L. Swenson, 2007, Journal of Biological Chemistry.

Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.

Tara L. Kieffer, H. Chu, A. Kwong, 2007, Gastroenterology.

PHENOTYPIC AND STRUCTURAL ANALYSES OF HCV NS3 PROTEASE ARG 155 VARIANTS: SENSITIVITY TO TELAPREVIR (VX-950) AND INTERFERON ALPHA

A. Kwong, B. G. Rao, L. Swenson, 2007 .

Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease

H. Chu, A. Kwong, B. G. Rao, 2007, Antimicrobial Agents and Chemotherapy.

Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection

M. Diamond, A. Noueiry, B. Geiss, 2007, Journal of Virology.

Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects.

Tara L. Kieffer, A. Kwong, D. Bartels, 2008, The Journal of infectious diseases.

Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples

A. Kwong, J. Lippke, D. Bartels, 2013, Virology Journal.

Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit

M. Murcko, P. Charifson, A. Kwong, 2014, Antimicrobial Agents and Chemotherapy.

Phenotypic Characterization of Resistant Val 36 Variants of Hepatitis C Virus NS3-4A Serine Protease (cid:1)

H. Chu, A. Kwong, B. G. Rao, 2007 .

PS-073-Preclinical profile of HBV core protein inhibitor, ABI-H, a potent inhibitor of cccDNA generation in HBV infected cells

M. Bures, R. Colonno, Yi Zhou, 2019, Journal of Hepatology.

Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection

M. Diamond, A. Noueiry, B. Geiss, 2007, Journal of Virology.